pharmaceuticals
Alzheimer’s disease market across 8MM to hit 19.3b by 2033
Alzheimer’s disease market across 8MM to hit 19.3b by 2033
DMTs are expected to account for 73.5% of the global market.
2 hours ago
Glaucoma market to hit $2.5b in seven major markets by 2033
A report predicts the launch of six late-stage pipeline drugs during this period.
4 days ago
Global testosterone replacement therapy market to rise by $461m by 2029
Its growth is driven by a rising awareness of hypogonadism.
5 days ago
Heart failure market across 7MM to grow at 9.6% CAGR until 2032
One driver is the introduction of drugs targeting unmet needs.
5 days ago
Global pharmaceutical data and analytics market to double by 2028
China represents the largest market for the sector.
Global heparin market to grow by $3.34b by 2028
Key developments include fractionated and low-molecular-weight heparin for thrombosis management.
8MM respiratory syncytial virus prophylaxis market to hit $6.2b by 2030
Thanks to the introduction of new monoclonal antibodies and vaccines.
India’s biotech ambitions face talent and IP challenges
These concerns may lead to a struggle to attract leading drugmakers.
Pharma dose CMOs face slow growth amidst challenging market conditions
The global shortage of generic drugs has worsened over the past year.
Hong Kong pharmaceutical market to be valued at $3b by 2028
However, competition from neighbouring markets poses downside risks.
AI to accelerate drug discovery and development timelines
Over 3,000 drugs have been developed or repurposed using AI.
Malaysian pharmaceutical market to project modest growth amidst new reform
A new procurement system aims to address medicine shortages and supply chain disruptions.
South Korea’s pharmaceutical market to benefit rising clinical trial activity
The sector is projected to reach $40.6b in 2028.
Skills shortage hinders digital transformation in the pharma industry
Large and medium-sized companies view this as a greater concern compared to smaller enterprises.
Pharmaceutical firms eye multiple myeloma amidst rising incidence rates
The increase has been faster in women since 2000.
South Korea’s pharmaceutical sales to hit $40.6b by 2028
It is expected to rise at a compound annual growth rate of 10% in US dollar terms.
7MM Parkinson’s disease pipeline focuses on disease-modifying agents
There are a total of 93 products in Phase I-III development for PD treatment.
Most Read
1. Disa unit inks licensing agreement to commercialise cataract screening device 2. Sunway Medical Centre Ipoh to open in early Q2 3. New Communicable Diseases Agency to be set up in first half of 2025 4. KPMG’s Peter Liddell advocates resilient healthcare solutions 5. NTUH and AbbVie partner to advance digital strategies for clinical trialsResource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
He discussed the pressing challenges and transformative solutions shaping the future of healthcare in the Asia Pacific.
